Translational Mass Spectrometry

The Central Proteomics Facility (Headington Site) has recently established a number of collaborations with clinical researches on campus, which includes the development of proteomics based approaches for the discovery of potential prognostic and diagnostic biomarkers. Ongoing research projects are focused on:


Agilent LCThese projects are funded by the Biomedical Research Centre (BRC) Oxford (UK), MRC (UK), Action Medical Research (UK) and CHAVI NIH (USA). For additional information, please visit our Central Proteomics Facility pages.